ID   LIMK2_HUMAN             Reviewed;         638 AA.
AC   P53671; A8K6H5; Q7KZ80; Q7L3H5; Q96E10; Q99464; Q9UFU0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   12-OCT-2022, entry version 213.
DE   RecName: Full=LIM domain kinase 2;
DE            Short=LIMK-2;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:22328514, ECO:0000269|PubMed:8537403};
GN   Name=LIMK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LIMK2A), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   TISSUE=Hepatoma;
RX   PubMed=8537403; DOI=10.1074/jbc.270.52.31321;
RA   Okano I., Hiraoka J., Otera H., Nunoue K., Ohashi K., Iwashita S.,
RA   Hirai M., Mizuno K.;
RT   "Identification and characterization of a novel family of serine/threonine
RT   kinases containing two N-terminal LIM motifs.";
RL   J. Biol. Chem. 270:31321-31330(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LIMK2A AND LIMK2B), SELF-INTERACTION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=8954941; DOI=10.1006/bbrc.1996.1847;
RA   Osada H., Hasada K., Inazawa J., Uchida K., Ueda R., Takahashi T.,
RA   Takahashi T.;
RT   "Subcellular localization and protein interaction of the human LIMK2 gene
RT   expressing alternative transcripts with tissue-specific regulation.";
RL   Biochem. Biophys. Res. Commun. 229:582-589(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LIMK2B).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LIMK2A).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LIMK2A).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH MARF1.
RA   Miyamoto K., Nakamura T., Shirakawa K., Matsumoto K.;
RT   "Molecular cloning and characterization of novel large protein, limkain b1,
RT   which associates with the LIM-kinase 2.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ROCK1.
RX   PubMed=10436159; DOI=10.1126/science.285.5429.895;
RA   Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A.,
RA   Obinata T., Ohashi K., Mizuno K., Narumiya S.;
RT   "Signaling from Rho to the actin cytoskeleton through protein kinases ROCK
RT   and LIM-kinase.";
RL   Science 285:895-898(1999).
RN   [11]
RP   PHOSPHORYLATION AT THR-505, MUTAGENESIS OF THR-505, FUNCTION, AND
RP   INTERACTION WITH ROCK1.
RX   PubMed=11018042; DOI=10.1074/jbc.m007074200;
RA   Sumi T., Matsumoto K., Nakamura T.;
RT   "Specific activation of LIM kinase 2 via phosphorylation of threonine 505
RT   by ROCK, a Rho-dependent protein kinase.";
RL   J. Biol. Chem. 276:670-676(2001).
RN   [12]
RP   PHOSPHORYLATION AT THR-505 BY CDC42BP.
RX   PubMed=11340065; DOI=10.1074/jbc.c100196200;
RA   Sumi T., Matsumoto K., Shibuya A., Nakamura T.;
RT   "Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-
RT   binding kinase alpha.";
RL   J. Biol. Chem. 276:23092-23096(2001).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210 AND SER-293, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293 AND SER-298, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-451
RP   AND THR-505, AND ACTIVE SITE.
RX   PubMed=22328514; DOI=10.1242/jcs.096818;
RA   Heng Y.W., Lim H.H., Mina T., Utomo P., Zhong S., Lim C.T., Koh C.G.;
RT   "TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule
RT   organization and spindle orientation.";
RL   J. Cell Sci. 125:1579-1590(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25849865; DOI=10.1038/ncomms7781;
RA   Kim J., Jo H., Hong H., Kim M.H., Kim J.M., Lee J.K., Heo W.D., Kim J.;
RT   "Actin remodelling factors control ciliogenesis by regulating YAP/TAZ
RT   activity and vesicle trafficking.";
RL   Nat. Commun. 6:6781-6781(2015).
RN   [19]
RP   STRUCTURE BY NMR OF 62-129.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the second LIM domain of human LIM-kinase 2
RT   (LIMK2).";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-35; ASN-45; CYS-213; ARG-296 AND
RP   CYS-418.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that plays an essential role
CC       in the regulation of actin filament dynamics (PubMed:10436159,
CC       PubMed:11018042). Acts downstream of several Rho family GTPase signal
CC       transduction pathways (PubMed:10436159, PubMed:11018042). Involved in
CC       astral microtubule organization and mitotic spindle orientation during
CC       early stages of mitosis by mediating phosphorylation of TPPP
CC       (PubMed:22328514). Displays serine/threonine-specific phosphorylation
CC       of myelin basic protein and histone (MBP) in vitro (PubMed:8537403).
CC       Suppresses ciliogenesis via multiple pathways; phosphorylation of CFL1,
CC       suppression of directional trafficking of ciliary vesicles to the
CC       ciliary base, and by facilitating YAP1 nuclear localization where it
CC       acts as a transcriptional corepressor of the TEAD4 target genes AURKA
CC       and PLK1 (PubMed:25849865). {ECO:0000269|PubMed:10436159,
CC       ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:22328514,
CC       ECO:0000269|PubMed:25849865, ECO:0000269|PubMed:8537403}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:22328514, ECO:0000269|PubMed:8537403};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000269|PubMed:22328514};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:22328514,
CC         ECO:0000269|PubMed:8537403};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000269|PubMed:22328514};
CC   -!- SUBUNIT: [Isoform LIMK2a]: Interacts with LIMK2b.
CC       {ECO:0000269|PubMed:8954941}.
CC   -!- SUBUNIT: [Isoform LIMK2b]: Interacts with LIMK2a.
CC       {ECO:0000269|PubMed:8954941}.
CC   -!- SUBUNIT: Binds ROCK1 and MARF1 (Ref.9, PubMed:11018042,
CC       PubMed:10436159). Interacts with NISCH (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BJ34, ECO:0000269|PubMed:10436159,
CC       ECO:0000269|PubMed:11018042, ECO:0000269|Ref.9}.
CC   -!- INTERACTION:
CC       P53671; Q16543: CDC37; NbExp=2; IntAct=EBI-1384350, EBI-295634;
CC       P53671; P08238: HSP90AB1; NbExp=3; IntAct=EBI-1384350, EBI-352572;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:22328514}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:25849865}.
CC   -!- SUBCELLULAR LOCATION: [Isoform LIMK2a]: Cytoplasm
CC       {ECO:0000269|PubMed:8954941}. Nucleus {ECO:0000269|PubMed:8954941}.
CC   -!- SUBCELLULAR LOCATION: [Isoform LIMK2b]: Cytoplasm
CC       {ECO:0000269|PubMed:8954941}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:8954941}. Nucleus {ECO:0000269|PubMed:8954941}.
CC       Note=Mainly present in the cytoplasm and is scarcely translocated to
CC       the nucleus. {ECO:0000269|PubMed:8954941}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=LIMK2a {ECO:0000303|PubMed:8954941};
CC         IsoId=P53671-1; Sequence=Displayed;
CC       Name=LIMK2b {ECO:0000303|PubMed:8954941};
CC         IsoId=P53671-2; Sequence=VSP_012287;
CC       Name=3;
CC         IsoId=P53671-3; Sequence=VSP_012287, VSP_043332;
CC   -!- PTM: Phosphorylated on serine and/or threonine residues by ROCK1.
CC       {ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11340065}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB54055.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D45906; BAA08312.1; -; mRNA.
DR   EMBL; D85527; BAA12827.1; -; mRNA.
DR   EMBL; AL117466; CAB55941.1; -; mRNA.
DR   EMBL; CR456513; CAG30399.1; -; mRNA.
DR   EMBL; AK291640; BAF84329.1; -; mRNA.
DR   EMBL; AC002073; AAB54055.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC002073; AAB54056.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59954.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59956.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59958.1; -; Genomic_DNA.
DR   EMBL; BC013051; AAH13051.1; -; mRNA.
DR   CCDS; CCDS13891.1; -. [P53671-1]
DR   CCDS; CCDS13892.1; -. [P53671-2]
DR   CCDS; CCDS33637.1; -. [P53671-3]
DR   PIR; A59196; A59196.
DR   RefSeq; NP_001026971.1; NM_001031801.1. [P53671-3]
DR   RefSeq; NP_005560.1; NM_005569.3. [P53671-1]
DR   RefSeq; NP_057952.1; NM_016733.2. [P53671-2]
DR   PDB; 1X6A; NMR; -; A=62-129.
DR   PDB; 4TPT; X-ray; 2.60 A; A/B=330-632.
DR   PDB; 5NXD; X-ray; 1.90 A; A/B=330-632.
DR   PDB; 7QHG; X-ray; 1.45 A; A/B=330-632.
DR   PDBsum; 1X6A; -.
DR   PDBsum; 4TPT; -.
DR   PDBsum; 5NXD; -.
DR   PDBsum; 7QHG; -.
DR   AlphaFoldDB; P53671; -.
DR   SMR; P53671; -.
DR   BioGRID; 110173; 54.
DR   IntAct; P53671; 57.
DR   MINT; P53671; -.
DR   STRING; 9606.ENSP00000339916; -.
DR   BindingDB; P53671; -.
DR   ChEMBL; CHEMBL5932; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; P53671; -.
DR   GuidetoPHARMACOLOGY; 2055; -.
DR   GlyGen; P53671; 1 site, 1 Thr glycan (1 site).
DR   iPTMnet; P53671; -.
DR   PhosphoSitePlus; P53671; -.
DR   BioMuta; LIMK2; -.
DR   DMDM; 1708824; -.
DR   EPD; P53671; -.
DR   jPOST; P53671; -.
DR   MassIVE; P53671; -.
DR   MaxQB; P53671; -.
DR   PaxDb; P53671; -.
DR   PeptideAtlas; P53671; -.
DR   PRIDE; P53671; -.
DR   ProteomicsDB; 56602; -. [P53671-1]
DR   ProteomicsDB; 56603; -. [P53671-2]
DR   ProteomicsDB; 56604; -. [P53671-3]
DR   Antibodypedia; 2106; 578 antibodies from 37 providers.
DR   DNASU; 3985; -.
DR   Ensembl; ENST00000331728.9; ENSP00000332687.4; ENSG00000182541.18. [P53671-1]
DR   Ensembl; ENST00000333611.8; ENSP00000330470.4; ENSG00000182541.18. [P53671-2]
DR   Ensembl; ENST00000340552.4; ENSP00000339916.4; ENSG00000182541.18. [P53671-3]
DR   GeneID; 3985; -.
DR   KEGG; hsa:3985; -.
DR   MANE-Select; ENST00000331728.9; ENSP00000332687.4; NM_005569.4; NP_005560.1.
DR   UCSC; uc003akh.4; human. [P53671-1]
DR   CTD; 3985; -.
DR   DisGeNET; 3985; -.
DR   GeneCards; LIMK2; -.
DR   HGNC; HGNC:6614; LIMK2.
DR   HPA; ENSG00000182541; Low tissue specificity.
DR   MIM; 601988; gene.
DR   neXtProt; NX_P53671; -.
DR   OpenTargets; ENSG00000182541; -.
DR   PharmGKB; PA30387; -.
DR   VEuPathDB; HostDB:ENSG00000182541; -.
DR   eggNOG; KOG1187; Eukaryota.
DR   GeneTree; ENSGT00940000159133; -.
DR   HOGENOM; CLU_000288_7_23_1; -.
DR   InParanoid; P53671; -.
DR   OMA; NAGHSPT; -.
DR   OrthoDB; 988822at2759; -.
DR   PhylomeDB; P53671; -.
DR   TreeFam; TF318014; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; P53671; -.
DR   Reactome; R-HSA-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   SignaLink; P53671; -.
DR   SIGNOR; P53671; -.
DR   BioGRID-ORCS; 3985; 14 hits in 1114 CRISPR screens.
DR   ChiTaRS; LIMK2; human.
DR   EvolutionaryTrace; P53671; -.
DR   GeneWiki; LIMK2; -.
DR   GenomeRNAi; 3985; -.
DR   Pharos; P53671; Tchem.
DR   PRO; PR:P53671; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P53671; protein.
DR   Bgee; ENSG00000182541; Expressed in cervix squamous epithelium and 190 other tissues.
DR   ExpressionAtlas; P53671; baseline and differential.
DR   Genevisible; P53671; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005801; C:cis-Golgi network; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0030953; P:astral microtubule organization; IDA:UniProtKB.
DR   GO; GO:0061303; P:cornea development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0051650; P:establishment of vesicle localization; IMP:UniProtKB.
DR   GO; GO:0060322; P:head development; IEA:Ensembl.
DR   GO; GO:1902018; P:negative regulation of cilium assembly; IMP:UniProtKB.
DR   GO; GO:0016310; P:phosphorylation; TAS:UniProtKB.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IMP:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 2.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   SMART; SM00132; LIM; 2.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Cytoskeleton;
KW   Kinase; LIM domain; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc.
FT   CHAIN           1..638
FT                   /note="LIM domain kinase 2"
FT                   /id="PRO_0000075809"
FT   DOMAIN          12..63
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          72..124
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          152..239
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          331..608
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          279..304
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        451
FT                   /evidence="ECO:0000269|PubMed:22328514"
FT   BINDING         337..345
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         360
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         210
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         293
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         505
FT                   /note="Phosphothreonine; by ROCK1 and CDC42BP"
FT                   /evidence="ECO:0000269|PubMed:11018042,
FT                   ECO:0000269|PubMed:11340065"
FT   VAR_SEQ         1..37
FT                   /note="MSALAGEDVWRCPGCGDHIAPSQIWYRTVNETWHGSC -> MGSYLSVPAYF
FT                   TSRDL (in isoform LIMK2b and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11230166,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8954941"
FT                   /id="VSP_012287"
FT   VAR_SEQ         592..638
FT                   /note="PAFSKLEDSFEALSLYLGELGIPLPAELEELDHTVSMQYGLTRDSPP -> A
FT                   PPGAAGEGPGCADDEGPVRRQGKVTIKYDPKELRKHLNLEEWILEQLTRLYDCQEEEIS
FT                   ELEIDVDELLDMESDDAWASRVKELLVDCYKPTEAFISGLLDKIRAMQKLSTPQKK
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043332"
FT   VARIANT         35
FT                   /note="G -> S (in dbSNP:rs5997917)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_034069"
FT   VARIANT         45
FT                   /note="D -> N (in dbSNP:rs35923988)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042249"
FT   VARIANT         213
FT                   /note="R -> C (in dbSNP:rs34930775)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042250"
FT   VARIANT         296
FT                   /note="P -> R (in dbSNP:rs34875793)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042251"
FT   VARIANT         381
FT                   /note="R -> H (in dbSNP:rs2229874)"
FT                   /id="VAR_050149"
FT   VARIANT         418
FT                   /note="R -> C (in dbSNP:rs35422808)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042252"
FT   MUTAGEN         451
FT                   /note="D->A: Abrogates kinase activity."
FT                   /evidence="ECO:0000269|PubMed:22328514"
FT   MUTAGEN         505
FT                   /note="T->E: Phosphomimetic mutant; enhances kinase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:11018042,
FT                   ECO:0000269|PubMed:22328514"
FT   MUTAGEN         505
FT                   /note="T->V: Abolishes cofilin phosphorylation and
FT                   enhancement of stress fiber formation."
FT                   /evidence="ECO:0000269|PubMed:11018042"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:1X6A"
FT   TURN            99..101
FT                   /evidence="ECO:0007829|PDB:1X6A"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:1X6A"
FT   STRAND          115..117
FT                   /evidence="ECO:0007829|PDB:1X6A"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:1X6A"
FT   HELIX           122..129
FT                   /evidence="ECO:0007829|PDB:1X6A"
FT   STRAND          331..337
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           341..343
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          345..350
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   TURN            351..353
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          356..361
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           367..375
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           377..382
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          391..397
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          400..406
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           413..418
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           425..444
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          456..460
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          465..467
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          506..508
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           510..512
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           515..518
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           527..541
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           547..549
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           560..567
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           576..583
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           588..590
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   HELIX           594..608
FT                   /evidence="ECO:0007829|PDB:7QHG"
FT   STRAND          609..611
FT                   /evidence="ECO:0007829|PDB:4TPT"
FT   HELIX           617..630
FT                   /evidence="ECO:0007829|PDB:7QHG"
SQ   SEQUENCE   638 AA;  72232 MW;  FB51813D99AFAC18 CRC64;
     MSALAGEDVW RCPGCGDHIA PSQIWYRTVN ETWHGSCFRC SECQDSLTNW YYEKDGKLYC
     PKDYWGKFGE FCHGCSLLMT GPFMVAGEFK YHPECFACMS CKVIIEDGDA YALVQHATLY
     CGKCHNEVVL APMFERLSTE SVQEQLPYSV TLISMPATTE GRRGFSVSVE SACSNYATTV
     QVKEVNRMHI SPNNRNAIHP GDRILEINGT PVRTLRVEEV EDAISQTSQT LQLLIEHDPV
     SQRLDQLRLE ARLAPHMQNA GHPHALSTLD TKENLEGTLR RRSLRRSNSI SKSPGPSSPK
     EPLLFSRDIS RSESLRCSSS YSQQIFRPCD LIHGEVLGKG FFGQAIKVTH KATGKVMVMK
     ELIRCDEETQ KTFLTEVKVM RSLDHPNVLK FIGVLYKDKK LNLLTEYIEG GTLKDFLRSM
     DPFPWQQKVR FAKGIASGMA YLHSMCIIHR DLNSHNCLIK LDKTVVVADF GLSRLIVEER
     KRAPMEKATT KKRTLRKNDR KKRYTVVGNP YWMAPEMLNG KSYDETVDIF SFGIVLCEII
     GQVYADPDCL PRTLDFGLNV KLFWEKFVPT DCPPAFFPLA AICCRLEPES RPAFSKLEDS
     FEALSLYLGE LGIPLPAELE ELDHTVSMQY GLTRDSPP
//
